Ladenburg Thalmann Upgrades Tenax Therapeutics (TENX) to Buy

May 18, 2017 7:45 AM EDT Send to a Friend
Ladenburg Thalmann upgraded Tenax Therapeutics (NASDAQ: TENX) from Neutral to Buy with a price target of $2.50.Analyst Jeffrey Cohen notes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login